Giovanni Scambia, PhD
Full Professor
Catholic University of the Sacred Heart
Largo A. Gemelli
1
Milan
Italy
20123
Papers:
4
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of concept
67
Chemoradiation vs. neoadjuvant chemoradiation followed by radical surgery for FIGO stage III cervical cancer: analysis of complications and 3-year survival
282
Feasibility of tertiary and quaternary cytoreduction in recurrent epithelial ovarian cancer
309
Comparison of quality of life after secondary cytoreductive surgery (SCS) ± HIPEC in recurrent ovarian cancer
329
Role of PDZ binding kinase (PBK) associated to guanylate binding protein 1 (GBP1) for drug resistance in ovarian cancer
330
The ratio between type 1 and type 2 tumor-associated macrophages predicts prognosis in patients with locally advanced cervical cancer receiving chemoradiation
366
Minimally invasive interval debulking surgery in AEOC: preliminary results from the MISSION trial
418
The GRO-SNaPET study: preliminary data on the prediction of lymphonodal status by sentinel lymph node biopsy combined with 18FDG-PET/CT to overcome the current limits of vulvar cancer treatment
Application of the laparoscopic predictive model for the prediction of complete cytoreduction in advanced epithelial ovarian cancer: the ‘Fagotti Score’
TELELAP ALF-X assisted laparoscopy for total hysterectomy: first human report
LEG VIDEO ENDOSCOPIC GROIN LYMPHADENECTOMY IN VULVAR CANCER
Phase III SCORPION trial (ID number: NCT01461850) in epithelial ovarian cancer patients with high tumor load receiving PDS versus NACT: ad interim analysis on peri-operative outcome